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Introduction
Juvenile Idiopathic Arthritis (JIA) is the most common
form of chronic arthritis in children. JIA is characterized
by onset of disease before the age of 16, with arthritis
lasting >6 weeks, and with an unknown cause. Among
JIA, seven sub-groups based on clinical and biological
features have been individualized namely: systemic
arthritis (sJIA) with autoinflammatory conditions, persis-
tent and extended oligoarthritis (per-oJIA and ext-oJIA,
respectively), rheumatoid factor-positive polyarthritis
(RFpos-pJIA), enthesitis-related arthritis (ERA), psoriatic
arthritis (PsA), and undifferentiated arthritis. Physio-
pathology of JIA is complex and JIA is considered to be
a multifactorial disease due to the combination of
genetic and environmental factors. Searching for genetic
factors in JIA during the last decade, the introduction of
genome-wide association studies (GWAS) and whole-
exome sequencing have discovered several new loci
associated with JIA susceptibility and have identified the
disease-associated gene monogenic form of sJIA,
respectively.
However, despite these novel knowledge, our under-
standing of JIA pathogenesis still remains poorly elusive
and accumulating evidence supports genetic variability
as playing a key role in JIA development.
Objectives
The aim of our study is to identify novel genes involved
in AJI in order to identify novel signaling pathways.
Patients and methods
Thanks to a French National Hospital Research program
(PHRC) including five french recruitment centers (Mon-
tpellier, Nîmes, Nantes, Marseille and Bordeaux), we
have collected blood samples from 30 AJI patients and
their unaffected parents. Based on clinical and biological
data, the patients were classified in 5 groups: 1) oligoar-
ticular form and negative autoantibodies (n=5), 2) oli-
goarticular form and positive antibodies (n=5), 3)
polyarticular form and negative rheumatoid factor
(n=10), 4) polyarticular form and positive rheumatoid
factor (n=5) and 5) systemic form (n=5).
Results
Using a whole exome sequencing trio strategy (i.e.
patients and their unaffected parents) considering each
family separately, we identified sequence variants in sev-
eral candidate genes. Functional studies are ongoing in
an attempt to demonstrate the pathological roles of the
identified genetic variations.
Conclusion
Our results could contribute to development of diagnos-
tic tests, orientation of drug therapies as well as devel-
opment of novel therapeutic targets. In addition, this
study could demonstrate the ability to use whole exome
sequencing in the context of the development of perso-
nalized medicine.
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